JP2013543581A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543581A5
JP2013543581A5 JP2013529664A JP2013529664A JP2013543581A5 JP 2013543581 A5 JP2013543581 A5 JP 2013543581A5 JP 2013529664 A JP2013529664 A JP 2013529664A JP 2013529664 A JP2013529664 A JP 2013529664A JP 2013543581 A5 JP2013543581 A5 JP 2013543581A5
Authority
JP
Japan
Prior art keywords
individual
hbp
determining whether
concentration
bacterial meningitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013529664A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013543581A (ja
JP5891230B2 (ja
Filing date
Publication date
Priority claimed from GBGB1016161.0A external-priority patent/GB201016161D0/en
Application filed filed Critical
Publication of JP2013543581A publication Critical patent/JP2013543581A/ja
Publication of JP2013543581A5 publication Critical patent/JP2013543581A5/ja
Application granted granted Critical
Publication of JP5891230B2 publication Critical patent/JP5891230B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013529664A 2010-09-24 2011-09-23 細菌性髄膜炎の治療方法 Active JP5891230B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1016161.0A GB201016161D0 (en) 2010-09-24 2010-09-24 Diagnostic method
GB1016161.0 2010-09-24
PCT/EP2011/066611 WO2012038541A1 (en) 2010-09-24 2011-09-23 Diagnostic method for bacterial meningitis

Publications (3)

Publication Number Publication Date
JP2013543581A JP2013543581A (ja) 2013-12-05
JP2013543581A5 true JP2013543581A5 (https=) 2014-10-02
JP5891230B2 JP5891230B2 (ja) 2016-03-22

Family

ID=43127976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013529664A Active JP5891230B2 (ja) 2010-09-24 2011-09-23 細菌性髄膜炎の治療方法

Country Status (6)

Country Link
US (1) US9759720B2 (https=)
EP (1) EP2619583B1 (https=)
JP (1) JP5891230B2 (https=)
CN (1) CN103250054B (https=)
GB (1) GB201016161D0 (https=)
WO (1) WO2012038541A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
GB201518597D0 (en) * 2015-10-20 2015-12-02 Univ Liverpool Detection of bacterial infection
US11287396B2 (en) 2020-06-05 2022-03-29 Princeton Biochemicals, Inc. Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用
CN111951969A (zh) * 2020-08-05 2020-11-17 中翰盛泰生物技术股份有限公司 Hbp在高危妊娠预测中的应用
CN121513038A (zh) * 2026-01-16 2026-02-13 湖北工业大学 包含舒洛地特和头孢曲松的组合物在制备治疗细菌性脑膜炎的药物中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
RU2200573C2 (ru) * 1994-04-21 2003-03-20 Леукотех А/С Связывающий гепарин белок для лечения сепсиса
US5976536A (en) * 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
AU2003220034A1 (en) 2002-03-08 2003-09-22 Heloise, Anne, Pereira, Ph. D. An early detection marker for chronic inflammatory associated diseases
US7655480B2 (en) 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
WO2004016653A2 (en) 2002-08-15 2004-02-26 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
EP1638530A2 (en) 2003-06-20 2006-03-29 Royer Biomedical, INC. Drug polymer complexes
WO2005028512A1 (en) 2003-09-19 2005-03-31 Leukotech A/S Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp)
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
CA2605143A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
WO2007041623A2 (en) 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
GB0521276D0 (en) 2005-10-19 2005-11-30 Lewitt Moira S Medical uses and therapies based upon the action of azurocidin on IGFBP-1
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Similar Documents

Publication Publication Date Title
JP2013543581A5 (https=)
Høiby et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014
JP2014521089A5 (https=)
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
WO2012142301A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
EP2240109A4 (en) SYSTEMS AND METHOD FOR THE STUDY, DIAGNOSTIC, TREATMENT AND / OR MONITORING OF TISSUE
WO2015014903A3 (en) Diagnostic tools for alzheimer's disease
JP2017524130A5 (https=)
WO2006073682A3 (en) Diagnostic test
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
WO2017027685A3 (en) Antibody-based molecules specific for the truncated asp421 epitope of tau and their uses in the diagnosis and treatment of tauopathy
JP2014523525A5 (https=)
WO2011112670A3 (en) Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
WO2009133197A3 (en) Levels of april in serum and use in diagnostic methods
WO2013006034A3 (en) A diagnostic kit for the detection of early acute leptospirosis
EP2844776A4 (en) CANCER BLOOD TEST USING INSULATED BC200 RNA FROM PERIPHERAL BLOOD FOR THE DIAGNOSIS AND TREATMENT OF INVASIVE BREAST CANCER
Kováč et al. Milk amyloid A and selected serum proteins in cows suffering from mastitis
WO2010121834A3 (en) Irak kinase family as novel target and biomarker for alzheimer
Mohanasoundaram The prevalence of inducible clindamycin resistance among gram positive cocci from various clinical specimens
BR112013030646A2 (pt) uso diagnóstico de pró-somatostatina
BR112014007947A2 (pt) método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5
Hsu et al. Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery
US20170227534A1 (en) Urinary crystal detection method
WO2007046811A3 (en) Diagnostic markers of stroke and cerebral injury and methods of use thereof
EP2371376A4 (en) METHOD AND REAGENTS FOR DIAGNOSIS, PREVENTION AND TREATMENT OF INSULIN RESISTANCE